Showing all posts written by Thomas Woodland
While serving as a Fellow for the Center of Medical Innovation, he experienced a wide variety of innovation. Prior to his legal education, Thomas received a Bachelor's degree in Physics from the University of Utah.
Thomas worked as a summer associate at the firm in 2015 and joined the firm in 2016.
On January 22, 2018, a $50 million lawsuit was filed against the U.S. Food and Drug Administration (FDA) in the Central District of California. The complaint was filed by Semler Research Center Pvt. Ltd., a contract research organization
A voluntary agreement (link in Dutch) was consummated by the Dutch Ministry of Health, industry, and hospitals. According to an Emergo blog post, under the terms of the agreement, the Netherlands will adopt the US Food and Drug Administration’s
BioSig Technologies recently announced a ten-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. According to the press release, the agreement aims to advance clinical features of BioSig’s PURE EP